From nature to bedside: Pro-survival and cell death mechanisms as therapeutic targets in cancer treatment

Biotechnology Advances

Volumn 32, Issue 6, 2014, Pages 1111-1122

  Cerella, Claudia ^a   Teiten, Marie Hélène ^a   Radogna, Flavia ^a   Dicato, Mario ^a   Diederich, Marc ^b  

^a LABORATOIRE DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE DU CANCER   (Luxembourg)

^b Seoul National University   (South Korea)

Author keywords

Apoptosis; Autophagy; Necrosis; Reactive oxygen species

Indexed keywords

CELL SIGNALING; DISEASES; PATIENT TREATMENT; PHYSIOLOGICAL MODELS; REACTIVE OXYGEN SPECIES; SCAFFOLDS (BIOLOGY); TISSUE HOMEOSTASIS; TUMORS;

AUTOPHAGY; BIOACTIVE SCAFFOLD; CELL-DEATH PATHWAYS; CRITICAL FACTORS; NECROSIS; PHYSIOLOGICAL REGULATORS; SIGNALING PATHWAYS; THERAPEUTIC TARGETS;

CELL DEATH;

ANTINEOPLASTIC AGENT; REACTIVE OXYGEN METABOLITE;

CELL DEATH; DRUG DEVELOPMENT; DRUG EFFECTS; HUMAN; METABOLISM; NEOPLASMS; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL DEATH; CELL LINE, TUMOR; DRUG DISCOVERY; HUMANS; NEOPLASMS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84926257214     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2014.03.006     Document Type: Review

References (176)

1. Aggarwal B.B., Shishodia S. Suppression of the nuclear factor-kappaB activation pathway by spice-derived phytochemicals: reasoning for seasoning. Ann N Y Acad Sci 2004, 1030:434-441.
2. Aggarwal B.B., Sung B. NF-kappaB in cancer: a matter of life and death. Cancer Discov 2011, 1:469-471.
3. Ahsan H., Hadi S.M. Strand scission in DNA induced by curcumin in the presence of Cu(II). Cancer Lett 1998, 124:23-30.
4. Allan L.A., Clarke P.R. Phosphorylation of caspase-9 by CDK1/cyclin B1 protects mitotic cells against apoptosis. Mol Cell 2007, 26:301-310.
5. Aoki H., Takada Y., Kondo S., Sawaya R., Aggarwal B.B., Kondo Y. Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways. Mol Pharmacol 2007, 72:29-39.
6. Bajwa N., Liao C., Nikolovska-Coleska Z. Inhibitors of the anti-apoptotic Bcl-2 proteins: a patent review. Expert Opin Ther Pat 2012, 22:37-55.
7. Bana E., Sibille E., Valente S., Cerella C., Chaimbault P., Kirsch G., et al. A novel coumarin-quinone derivative SV37 inhibits CDC25 phosphatases, impairs proliferation, and induces cell death. Mol Carcinog 2013, 10.1002/mc.22094.
8. Banerjee M., Singh P., Panda D. Curcumin suppresses the dynamic instability of microtubules, activates the mitotic checkpoint and induces apoptosis in MCF-7 cells. FEBS J 2010, 277:3437-3448.
9. Banerjee S., Choi M., Aboukameel A., Wang Z., Mohammad M., Chen J., et al. Preclinical studies of apogossypolone, a novel pan inhibitor of bcl-2 and mcl-1, synergistically potentiates cytotoxic effect of gemcitabine in pancreatic cancer cells. Pancreas 2010, 39:323-331.
10. Basu A., Haldar S. Microtubule-damaging drugs triggered bcl2 phosphorylation-requirement of phosphorylation on both serine-70 and serine-87 residues of bcl2 protein. Int J Oncol 1998, 13:659-664.
11. Beevers C.S., Li F., Liu L., Huang S. Curcumin inhibits the mammalian target of rapamycin-mediated signaling pathways in cancer cells. Int J Cancer 2006, 119:757-764.
12. Beevers C.S., Chen L., Liu L., Luo Y., Webster N.J., Huang S. Curcumin disrupts the mammalian target of rapamycin-raptor complex. Cancer Res 2009, 69:1000-1008.
13. Bertrand M.J., Vandenabeele P. The ripoptosome: death decision in the cytosol. Mol Cell 2011, 43:323-325.
14. Bhat S.H., Azmi A.S., Hadi S.M. Prooxidant DNA breakage induced by caffeic acid in human peripheral lymphocytes: involvement of endogenous copper and a putative mechanism for anticancer properties. Toxicol Appl Pharmacol 2007, 218:249-255.
15. Blagosklonny M.V. Unwinding the loop of Bcl-2 phosphorylation. Leukemia 2001, 15:869-874.
16. Bodur C., Basaga H. Bcl-2 inhibitors: emerging drugs in cancer therapy. Curr Med Chem 2012, 19:1804-1820.
17. Bollag D.M., McQueney P.A., Zhu J., Hensens O., Koupal L., Liesch J., et al. Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action. Cancer Res 1995, 55:2325-2333.
18. Borzilleri R., Vite G. Epothilones: new tubulin polymerization agents in preclinical and clinical development. Drugs Future 2002, 27:1149-1163.
19. Braig S., Wiedmann R.M., Liebl J., Singer M., Kubisch R., Schreiner L., et al. Pretubulysin: a new option for the treatment of metastatic cancer. Cell Death Dis 2014, 5:e1001.
20. Bremner P., Heinrich M. Natural products as targeted modulators of the nuclear factor-kappaB pathway. J Pharm Pharmacol 2002, 54:453-472.
21. Cao A., Li Q., Yin P., Dong Y., Shi H., Wang L., et al. Curcumin induces apoptosis in human gastric carcinoma AGS cells and colon carcinoma HT-29 cells through mitochondrial dysfunction and endoplasmic reticulum stress. Apoptosis 2013, 18:1391-1402.
22. Caputo F., Vegliante R., Ghibelli L. Redox modulation of the DNA damage response. Biochem Pharmacol 2012, 84:1292-1306.
23. Castino R., Fiorentino I., Cagnin M., Giovia A., Isidoro C. Chelation of lysosomal iron protects dopaminergic SH-SY5Y neuroblastoma cells from hydrogen peroxide toxicity by precluding autophagy and Akt dephosphorylation. Toxicol Sci 2011, 123:523-541.
24. Cecconi F., Alvarez-Bolado G., Meyer B.I., Roth K.A., Gruss P. Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development. Cell 1998, 94:727-737.
25. Cerella C., D'Alessio M., Cristofanon S., De Nicola M., Radogna F., Dicato M., et al. Subapoptogenic oxidative stress strongly increases the activity of the glycolytic key enzyme glyceraldehyde 3-phosphate dehydrogenase. Ann N Y Acad Sci 2009, 1171:583-590.
26. Cerella C., Diederich M., Ghibelli L. The dual role of calcium as messenger and stressor in cell damage, death, and survival. Int J Cell Biol 2010, 2010:546163.
27. Cerella C., Dicato M., Jacob C., Diederich M. Chemical properties and mechanisms determining the anti-cancer action of garlic-derived organic sulfur compounds. Anticancer Agents Med Chem 2011, 11:267-271.
28. Cerella C., Kelkel M., Viry E., Dicato M., Jacob C., Diederich M. Naturally occurring organic sulfur compounds: an example of a multitasking class of phytochemicals in anti-cancer research. Anti-cancer research, phytochemicals - bioactivities and impact on health 2011, 3-42. InTech, Rijeka, Croatia. P.I. Rasooli (Ed.).
29. Cerella C., Dicato M., Diederich M. Assembling the puzzle of anti-cancer mechanisms triggered by cardiac glycosides. Mitochondrion 2013, 13:225-234.
30. Cervia D., Martini D., Garcia-Gil M., Di Giuseppe G., Guella G., Dini F., et al. Cytotoxic effects and apoptotic signalling mechanisms of the sesquiterpenoid euplotin C, a secondary metabolite of the marine ciliate Euplotes crassus, in tumour cells. Apoptosis 2006, 11:829-843.
31. Chan S.L., Lee M.C., Tan K.O., Yang L.K., Lee A.S., Flotow H., et al. Identification of chelerythrine as an inhibitor of BclXL function. J Biol Chem 2003, 278:20453-20456.
32. Chen T., Stephens P.A., Middleton F.K., Curtin N.J. Targeting the S and G2 checkpoint to treat cancer. Drug Discov Today 2012, 17:194-202.
33. Cheng E.H., Wei M.C., Weiler S., Flavell R.A., Mak T.W., Lindsten T., et al. BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol Cell 2001, 8:705-711.
34. Cheng S., Gao N., Zhang Z., Chen G., Budhraja A., Ke Z., et al. Quercetin induces tumor-selective apoptosis through downregulation of Mcl-1 and activation of Bax. Clin Cancer Res 2010, 16:5679-5691.
35. Chiappori A.A., Schreeder M.T., Moezi M.M., Stephenson J.J., Blakely J., Salgia R., et al. A phase I trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small cell lung cancer. Br J Cancer 2012, 106:839-845.
36. Choudhury D., Ganguli A., Dastidar D.G., Acharya B.R., Das A., Chakrabarti G. Apigenin shows synergistic anticancer activity with curcumin by binding at different sites of tubulin. Biochimie 2013, 95:1297-1309.
37. Christodoulou M.I., Kontos C.K., Halabalaki M., Skaltsounis A.L., Scorilas A. Nature Promises New Anticancer Agents: Interplay with the Apoptosis-related BCL2 Gene Family. Anticancer Agents Med Chem 2014, 14:375-399.
38. Clohessy J.G., Zhuang J., de Boer J., Gil-Gomez G., Brady H.J. Mcl-1 interacts with truncated Bid and inhibits its induction of cytochrome c release and its role in receptor-mediated apoptosis. J Biol Chem 2006, 281:5750-5759.
39. Coates R.J., Weiss N.S., Daling J.R., Rettmer R.L., Warnick G.R. Cancer risk in relation to serum copper levels. Cancer Res 1989, 49:4353-4356.
40. Cossu F., Milani M., Mastrangelo E., Vachette P., Servida F., Lecis D., et al. Structural basis for bivalent Smac-mimetics recognition in the IAP protein family. J Mol Biol 2009, 392:630-644.
41. Danial N.N. BCL-2 family proteins: critical checkpoints of apoptotic cell death. Clin Cancer Res 2007, 13:7254-7263.
42. Davids M.S., Letai A. Targeting the B-cell lymphoma/leukemia 2 family in cancer. J Clin Oncol 2012, 30:3127-3135.
43. Degenhardt K., Mathew R., Beaudoin B., Bray K., Anderson D., Chen G., et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 2006, 10:51-64.
44. Degterev A., Boyce M., Yuan J. A decade of caspases. Oncogene 2003, 22:8543-8567.
45. Deveraux Q.L., Reed J.C. IAP family proteins-suppressors of apoptosis. Genes Dev 1999, 13:239-252.
46. Doi K., Li R., Sung S.S., Wu H., Liu Y., Manieri W., et al. Discovery of marinopyrrole A (maritoclax) as a selective Mcl-1 antagonist that overcomes ABT-737 resistance by binding to and targeting Mcl-1 for proteasomal degradation. J Biol Chem 2012, 287:10224-10235.
47. Du C., Fang M., Li Y., Li L., Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000, 102:33-42.
48. Eguchi Y., Shimizu S., Tsujimoto Y. Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res 1997, 57:1835-1840.
49. Feoktistova M., Geserick P., Kellert B., Dimitrova D.P., Langlais C., Hupe M., et al. cIAPs block ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol Cell 2011, 43:449-463.
50. Filippi-Chiela E.C., Villodre E.S., Zamin L.L., Lenz G. Autophagy interplay with apoptosis and cell cycle regulation in the growth inhibiting effect of resveratrol in glioma cells. PloS One 2011, 6:e20849.
51. Fisher D., Krasinska L., Coudreuse D., Novak B. Phosphorylation network dynamics in the control of cell cycle transitions. J Cell Sci 2012, 125:4703-4711.
52. Folmer F., Harrison W.T., Tabudravu J.N., Jaspars M., Aalbersberg W., Feussner K., et al. NF-kappaB-inhibiting naphthopyrones from the Fijian echinoderm Comanthus parvicirrus. J Nat Prod 2008, 71:106-111.
53. Folmer F., Dicato M., Diederich M. From the deepest sea shelf to the uppermost kitchen cabinet shelf: the quest for novel TNF-alpha inhibitors. Curr Top Med Chem 2012, 12:1392-1407.
54. Fulda S., Debatin K.M. Modulation of apoptosis signaling for cancer therapy. Arch Immunol Ther Exp (Warsz) 2006, 54:173-175.
55. Galonek H.L., Hardwick J.M. Upgrading the BCL-2 network. Nat Cell Biol 2006, 8:1317-1319.
56. Gossner G., Choi M., Tan L., Fogoros S., Griffith K.A., Kuenker M., et al. Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells. Gynecol Oncol 2007, 105:23-30.
57. Gyrd-Hansen M., Meier P. IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer. Nat Rev Cancer 2010, 10:561-574.
58. Hadi S.M., Bhat S.H., Azmi A.S., Hanif S., Shamim U., Ullah M.F. Oxidative breakage of cellular DNA by plant polyphenols: a putative mechanism for anticancer properties. Semin Cancer Biol 2007, 17:370-376.
59. Harikumar K.B., Sung B., Tharakan S.T., Pandey M.K., Joy B., Guha S., et al. Sesamin manifests chemopreventive effects through the suppression of NF-kappa B-regulated cell survival, proliferation, invasion, and angiogenic gene products. Mol Cancer Res 2010, 8:751-761.
60. Harley M.E., Allan L.A., Sanderson H.S., Clarke P.R. Phosphorylation of Mcl-1 by CDK1-cyclin B1 initiates its Cdc20-dependent destruction during mitotic arrest. EMBO J 2010, 29:2407-2420.
61. He C., Levine B. The Beclin 1 interactome. Curr Opin Cell Biol 2010, 22:140-149.
62. Hetz C., Chevet E., Harding H.P. Targeting the unfolded protein response in disease. Nat Rev Drug Discov 2013, 12:703-719.
63. Holler N., Zaru R., Micheau O., Thome M., Attinger A., Valitutti S., et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 2000, 1:489-495.
64. Hosono T., Fukao T., Ogihara J., Ito Y., Shiba H., Seki T., et al. Diallyl trisulfide suppresses the proliferation and induces apoptosis of human colon cancer cells through oxidative modification of beta-tubulin. J Biol Chem 2005, 280:41487-41493.
65. Hosseini A., Espona-Fiedler M., Soto-Cerrato V., Quesada R., Perez-Tomas R., Guallar V. Molecular interactions of prodiginines with the BH3 domain of anti-apoptotic Bcl-2 family members. PloS One 2013, 8:e57562.
66. Isomura M., Kotake Y., Masuda K., Miyara M., Okuda K., Samizo S., et al. Tributyltin-induced endoplasmic reticulum stress and its Ca(2+)-mediated mechanism. Toxicol Appl Pharmacol 2013, 272:137-146.
67. Jiang H., Zhang L., Kuo J., Kuo K., Gautam S.C., Groc L., et al. Resveratrol-induced apoptotic death in human U251 glioma cells. Mol Cancer Ther 2005, 4:554-561.
68. Juncker T., Cerella C., Teiten M.H., Morceau F., Schumacher M., Ghelfi J., et al. UNBS1450, a steroid cardiac glycoside inducing apoptotic cell death in human leukemia cells. Biochem Pharmacol 2011, 81:13-23.
69. Karin M., Greten F.R. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005, 5:749-759.
70. Karin M., Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol 2002, 3:221-227.
71. Kaur G., Hollingshead M., Holbeck S., Schauer-Vukasinovic V., Camalier R.F., Domling A., et al. Biological evaluation of tubulysin A: a potential anticancer and antiangiogenic natural product. Biochem J 2006, 396:235-242.
72. Kavallaris M. Microtubules and resistance to tubulin-binding agents. Nat Rev Cancer 2010, 10:194-204.
73. Kelkel M., Cerella C., Mack F., Schneider T., Jacob C., Schumacher M., et al. ROS-independent JNK activation and multisite phosphorylation of Bcl-2 link diallyl tetrasulfide-induced mitotic arrest to apoptosis. Carcinogenesis 2012, 33:2162-2171.
74. Kerr J.F., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972, 26:239-257.
75. Khalil M.W., Sasse F., Lunsdorf H., Elnakady Y.A., Reichenbach H. Mechanism of action of tubulysin, an antimitotic peptide from myxobacteria. Chembiochem 2006, 7:678-683.
76. Kitada S., Leone M., Sareth S., Zhai D., Reed J.C., Pellecchia M. Discovery, characterization, and structure-activity relationships studies of proapoptotic polyphenols targeting B-cell lymphocyte/leukemia-2 proteins. J Med Chem 2003, 46:4259-4264.
77. Knecht D.A., LaFleur R.A., Kahsai A.W., Argueta C.E., Beshir A.B.., Fenteany G. Cucurbitacin I inhibits cell motility by indirectly interfering with actin dynamics. PLoS One 2010, 5:e14039.
78. Kuwana T., Bouchier-Hayes L., Chipuk J.E., Bonzon C., Sullivan B.A., Green D.R., et al. BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol Cell 2005, 17:525-535.
79. Lambert J.D., Elias R.J. The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention. Arch Biochem Biophys 2010, 501:65-72.
80. Lane D.P. Cancer. p53, guardian of the genome. Nature 1992, 358:15-16.
81. Leamon C.P., Reddy J.A., Vetzel M., Dorton R., Westrick E., Parker N., et al. Folate targeting enables durable and specific antitumor responses from a therapeutically null tubulysin B analogue. Cancer Res 2008, 68:9839-9844.
82. Lee J.S., Li Q., Lee J.Y., Lee S.H., Jeong J.H., Lee H.R., et al. FLIP-mediated autophagy regulation in cell death control. Nat Cell Biol 2009, 11:1355-1362.
83. Leone M., Zhai D., Sareth S., Kitada S., Reed J.C., Pellecchia M. Cancer prevention by tea polyphenols is linked to their direct inhibition of antiapoptotic Bcl-2-family proteins. Cancer Res 2003, 63:8118-8121.
84. Lessene G., Czabotar P.E., Colman P.M. BCL-2 family antagonists for cancer therapy. Nat Rev Drug Discov 2008, 7:989-1000.
85. Letai A., Bassik M.C., Walensky L.D., Sorcinelli M.D., Weiler S., Korsmeyer S.J. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2002, 2:183-192.
86. Levine B., Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008, 132:27-42.
87. Levine B., Sinha S., Kroemer G. Bcl-2 family members: dual regulators of apoptosis and autophagy. Autophagy 2008, 4:600-606.
88. Li J., Qin Z., Liang Z. The prosurvival role of autophagy in resveratrol-induced cytotoxicity in human U251 glioma cells. BMC Cancer 2009, 9:215.
89. Lian J., Karnak D., Xu L. The Bcl-2-Beclin 1 interaction in (-)-gossypol-induced autophagy versus apoptosis in prostate cancer cells. Autophagy 2010, 6:1201-1203.
90. Lin Y., Devin A., Rodriguez Y., Liu Z.G. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev 1999, 13:2514-2526.
91. Liu Q., Wang H.G. Anti-cancer drug discovery and development: Bcl-2 family small molecule inhibitors. Commun Integr Biol 2012, 5:557-565.
92. Long J.S., Ryan K.M. New frontiers in promoting tumour cell death: targeting apoptosis, necroptosis and autophagy. Oncogene 2012, 31:5045-5060.
93. Lopez-Anton N., Rudy A., Barth N., Schmitz M.L., Pettit G.R., Schulze-Osthoff K., et al. The marine product cephalostatin 1 activates an endoplasmic reticulum stress-specific and apoptosome-independent apoptotic signaling pathway. J Biol Chem 2006, 281:33078-33086.
94. Los M., Van de Craen M., Penning L.C., Schenk H., Westendorp M., Baeuerle P.A., et al. Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature 1995, 375:81-83.
95. Lugovskoy A.A., Degterev A.I., Fahmy A.F., Zhou P., Gross J.D., Yuan J., et al. A novel approach for characterizing protein ligand complexes: molecular basis for specificity of small-molecule Bcl-2 inhibitors. J Am Chem Soc 2002, 124:1234-1240.
96. Maiuri M.C., Criollo A., Tasdemir E., Vicencio J.M., Tajeddine N., Hickman J.A., et al. BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin 1 and Bcl-2/Bcl-X(L). Autophagy 2007, 3:374-376.
97. Maiuri M.C., Zalckvar E., Kimchi A., Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 2007, 8:741-752.
98. Mathew R., Karp C.M., Beaudoin B., Vuong N., Chen G., Chen H.Y., et al. Autophagy suppresses tumorigenesis through elimination of p62. Cell 2009, 137:1062-1075.
99. Medema R.H., Lindqvist A. Boosting and suppressing mitotic phosphorylation. Trends Biochem Sci 2011, 36:578-584.
100. Mehrpour M., Esclatine A., Beau I., Codogno P. Overview of macroautophagy regulation in mammalian cells. Cell Res 2010, 20:748-762.
101. Meng Y., Tang W., Dai Y., Wu X., Liu M., Ji Q., et al. Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa. Mol Cancer Ther 2008, 7:2192-2202.
102. Misra J., Chanda D., Kim D.K., Li T., Koo S.H., Back S.H., et al. Curcumin differentially regulates endoplasmic reticulum stress through transcriptional corepressor SMILE (small heterodimer partner-interacting leucine zipper protein)-mediated inhibition of CREBH (cAMP responsive element-binding protein H). J Biol Chem 2011, 286:41972-41984.
103. Moon D.O., Kim M.O., Lee J.D., Choi Y.H., Kim G.Y. Rosmarinic acid sensitizes cell death through suppression of TNF-alpha-induced NF-kappaB activation and ROS generation in human leukemia U937 cells. Cancer Lett 2010, 288:183-191.
104. Moretti L., Li B., Kim K.W., Chen H., Lu B. AT-101, a pan-Bcl-2 inhibitor, leads to radiosensitization of non-small cell lung cancer. J Thorac Oncol 2010, 5:680-687.
105. Mozzetti S., Iantomasi R., De Maria I., Prislei S., Mariani M., Camperchioli A., et al. Molecular mechanisms of patupilone resistance. Cancer Res 2008, 68:10197-10204.
106. Nakashima S., Hiraku Y., Tada-Oikawa S., Hishita T., Gabazza E.C., Tamaki S., et al. Vacuolar H+-ATPase inhibitor induces apoptosis via lysosomal dysfunction in the human gastric cancer cell line MKN-1. J Biochem 2003, 134:359-364.
107. Nikolovska-Coleska Z., Xu L., Hu Z., Tomita Y., Li P., Roller P.P., et al. Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database. J Med Chem 2004, 47:2430-2440.
108. Opipari A.W., Tan L., Boitano A.E., Sorenson D.R., Aurora A., Liu J.R. Resveratrol-induced autophagocytosis in ovarian cancer cells. Cancer Res 2004, 64:696-703.
109. Orlikova B., Diederich M. Power from the garden: plant compounds as inhibitors of the hallmarks of cancer. Curr Med Chem 2012, 19:2061-2087.
110. Orlikova B., Tasdemir D., Golais F., Dicato M., Diederich M. The aromatic ketone 4'-hydroxychalcone inhibits TNFalpha-induced NF-kappaB activation via proteasome inhibition. Biochem Pharmacol 2011, 82:620-631.
111. Orlikova B., Tasdemir D., Golais F., Dicato M., Diederich M. Dietary chalcones with chemopreventive and chemotherapeutic potential. Genes Nutr 2011, 6:125-147.
112. Ozaki T., Nakagawara A. p73, a sophisticated p53 family member in the cancer world. Cancer Sci 2005, 96:729-737.
113. Pahl H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999, 18:6853-6866.
114. Park J.W., Choi Y.J., Suh S.I., Baek W.K., Suh M.H., Jin I.N., et al. Bcl-2 overexpression attenuates resveratrol-induced apoptosis in U937 cells by inhibition of caspase-3 activity. Carcinogenesis 2001, 22:1633-1639.
115. Polier G., Ding J., Konkimalla B.V., Eick D., Ribeiro N., Kohler R., et al. Wogonin and related natural flavones are inhibitors of CDK9 that induce apoptosis in cancer cells by transcriptional suppression of Mcl-1. Cell Death Dis 2011, 2:e182.
116. Quinn B.A., Dash R., Azab B., Sarkar S., Das S.K., Kumar S., et al. Targeting Mcl-1 for the therapy of cancer. Expert Opin Investig Drugs 2011, 20:1397-1411.
117. Radogna F., Cristofanon S., Paternoster L., D'Alessio M., De Nicola M., Cerella C., et al. Melatonin antagonizes the intrinsic pathway of apoptosis via mitochondrial targeting of Bcl-2. J Pineal Res 2008, 44:316-325.
118. Rahman A., Shahabuddin, Hadi S.M., Parish J.H., Ainley K. Strand scission in DNA induced by quercetin and Cu(II): role of Cu(I) and oxygen free radicals. Carcinogenesis 1989, 10:1833-1839.
119. Ready N., Karaseva N.A., Orlov S.V., Luft A.V., Popovych O., Holmlund J.T., et al. Double-blind, placebo-controlled, randomized phase 2 study of the proapoptotic agent AT-101 plus docetaxel, in second-line non-small cell lung cancer. J Thorac Oncol 2011, 6:781-785.
120. Reed J.C. Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Curr Opin Oncol 1995, 7:541-546.
121. Reed J.C. Drug insight: cancer therapy strategies based on restoration of endogenous cell death mechanisms. Nat Clin Pract Oncol 2006, 3:388-398.
122. Reuter S., Eifes S., Dicato M., Aggarwal B.B., Diederich M. Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells. Biochem Pharmacol 2008, 76:1340-1351.
123. Reuter S., Charlet J., Juncker T., Teiten M.H., Dicato M., Diederich M. Effect of curcumin on nuclear factor kappaB signaling pathways in human chronic myelogenous K562 leukemia cells. Ann N Y Acad Sci 2009, 1171:436-447.
124. Rieder C.L., Maiato H. Stuck in division or passing through: what happens when cells cannot satisfy the spindle assembly checkpoint. Dev Cell 2004, 7:637-651.
125. Rizvi S.A., Liu S., Chen Z., Skau C., Pytynia M., Kovar D.R., et al. Rationally simplified bistramide analog reversibly targets actin polymerization and inhibits cancer progression in vitro and in vivo. J Am Chem Soc 2010, 132:7288-7290.
126. Roos W.P., Kaina B. DNA damage-induced cell death by apoptosis. Trends Mol Med 2006, 12:440-450.
127. Rubinstein A.D., Eisenstein M., Ber Y., Bialik S., Kimchi A. The autophagy protein Atg12 associates with antiapoptotic Bcl-2 family members to promote mitochondrial apoptosis. Mol Cell 2011, 44:698-709.
128. Ruvolo P.P., Deng X., May W.S. Phosphorylation of Bcl2 and regulation of apoptosis. Leukemia 2001, 15:515-522.
129. Said Ahmad M., Fazal F., Rahman A., Hadi S.M., Parish J.H. Activities of flavonoids for the cleavage of DNA in the presence of Cu(II): correlation with generation of active oxygen species. Carcinogenesis 1992, 13:605-608.
130. Saidu N.E., Abu Asali I., Czepukojc B., Seitz B., Jacob C., Montenarh M. Comparison between the effects of diallyl tetrasulfide on human retina pigment epithelial cells (ARPE-19) and HCT116 cells. Biochim Biophys Acta 2013, 1830:5267-5276.
131. Salminen A., Lehtonen M., Suuronen T., Kaarniranta K., Huuskonen J. Terpenoids: natural inhibitors of NF-kappaB signaling with anti-inflammatory and anticancer potential. Cell Mol Life Sci 2008, 65:2979-2999.
132. Salvesen G.S., Duckett C.S. IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 2002, 3:401-410.
133. Samali A., Fulda S., Gorman A.M., Hori O., Srinivasula S.M. Cell stress and cell death. Int J Cell Biol 2010, 2010:245803.
134. Sasse F., Steinmetz H., Heil J., Hofle G., Reichenbach H. Tubulysins, new cytostatic peptides from myxobacteria acting on microtubuli. Production, isolation, physico-chemical and biological properties. J Antibiot 2000, 53:879-885.
135. Sawadogo W.R., Schumacher M., Teiten M.H., Cerella C., Dicato M., Diederich M. A survey of marine natural compounds and their derivatives with anti-cancer activity reported in 2011. Molecules 2013, 18:3641-3673.
136. Schumacher M., Cerella C., Eifes S., Chateauvieux S., Morceau F., Jaspars M., et al. Heteronemin, a spongean sesterterpene, inhibits TNF alpha-induced NF-kappa B activation through proteasome inhibition and induces apoptotic cell death. Biochem Pharmacol 2010, 79:610-622.
137. Schumacher M., Cerella C., Reuter S., Dicato M., Diederich M. Anti-inflammatory, pro-apoptotic, and anti-proliferative effects of a methanolic neem (Azadirachta indica) leaf extract are mediated via modulation of the nuclear factor-kappaB pathway. Genes Nutr 2011, 6:149-160.
138. Shamas-Din A., Brahmbhatt H., Leber B., Andrews D.W. BH3-only proteins: orchestrators of apoptosis. Biochim Biophys Acta 2011, 1813:508-520.
139. Shi Y. A conserved tetrapeptide motif: potentiating apoptosis through IAP-binding. Cell Death Differ 2002, 9:93-95.
140. Shimizu S., Kanaseki T., Mizushima N., Mizuta T., Arakawa-Kobayashi S., Thompson C.B., et al. Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat Cell Biol 2004, 6:1221-1228.
141. Shinojima N., Yokoyama T., Kondo Y., Kondo S. Roles of the Akt/mTOR/p70S6K and ERK1/2 signaling pathways in curcumin-induced autophagy. Autophagy 2007, 3:635-637.
142. Singh M., Singh R., Bhui K., Tyagi S., Mahmood Z., Shukla Y. Tea polyphenols induce apoptosis through mitochondrial pathway and by inhibiting nuclear factor-kappaB and Akt activation in human cervical cancer cells. Oncol Res 2011, 19:245-257.
143. Solomon V.R., Lee H. Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies. Eur J Pharmacol 2009, 625:220-233.
144. Soria G., Polo S.E., Almouzni G. Prime, repair, restore: the active role of chromatin in the DNA damage response. Mol Cell 2012, 46:722-734.
145. Spagnuolo C., Cerella C., Russo M., Chateauvieux S., Diederich M., Russo G.L. Quercetin downregulates Mcl-1 by acting on mRNA stability and protein degradation. Br J Cancer 2011, 105:221-230.
146. Statsuk A.V., Bai R., Baryza J.L., Verma V.A., Hamel E., Wender P.A., et al. Actin is the primary cellular receptor of bistramide A. Nat Chem Biol 2005, 1:383-388.
147. Stengel C., Newman S.P., Leese M.P., Potter B.V., Reed M.J., Purohit A. Class III beta-tubulin expression and in vitro resistance to microtubule targeting agents. Br J Cancer 2010, 102:316-324.
148. Surova O., Zhivotovsky B. Various modes of cell death induced by DNA damage. Oncogene 2013, 32:3789-3797.
149. Tabas I., Ron D. Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat Cell Biol 2011, 13:184-190.
150. Tanigaki K., Sasaki S., Ohkuma S. In bafilomycin A1-resistant cells, bafilomycin A1 raised lysosomal pH and both prodigiosins and concanamycin A inhibited growth through apoptosis. FEBS Lett 2003, 537:79-84.
151. Teiten M.H., Reuter S., Schumacher M., Dicato M., Diederich M. Induction of heat shock response by curcumin in human leukemia cells. Cancer Lett 2009, 279(2):145-154.
152. Teiten M.H., Eifes S., Dicato M., Diederich M. Curcumin-the paradigm of a multi-target natural compound with applications in cancer prevention and treatment. Toxins 2010, 2:128-162.
153. Teiten M.H., Gaascht F., Eifes S., Dicato M., Diederich M. Chemopreventive potential of curcumin in prostate cancer. Genes Nutr 2010, 5:61-74.
154. Teiten M.H., Mack F., Debbab A., Aly A.H., Dicato M., Proksch P., et al. Anticancer effect of altersolanol A, a metabolite produced by the endophytic fungus Stemphylium globuliferum, mediated by its pro-apoptotic and anti-invasive potential via the inhibition of NF-kappaB activity. Bioorg Med Chem 2013, 21:3850-3858.
155. Tenev T., Bianchi K., Darding M., Broemer M., Langlais C., Wallberg F., et al. The ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol Cell 2011, 43:432-448.
156. Thomas L.W., Lam C., Edwards S.W. Mcl-1; the molecular regulation of protein function. FEBS Lett 2010, 584:2981-2989.
157. Trincheri N.F., Follo C., Nicotra G., Peracchio C., Castino R., Isidoro C. Resveratrol-induced apoptosis depends on the lipid kinase activity of Vps34 and on the formation of autophagolysosomes. Carcinogenesis 2008, 29:381-389.
158. Trudel S., Li Z.H., Rauw J., Tiedemann R.E., Wen X.Y., Stewart A.K. Preclinical studies of the pan-Bcl inhibitor obatoclax (GX015-070) in multiple myeloma. Blood 2007, 109:5430-5438.
159. Voss V., Senft C., Lang V., Ronellenfitsch M.W., Steinbach J.P., Seifert V., et al. The pan-Bcl-2 inhibitor (-)-gossypol triggers autophagic cell death in malignant glioma. Mol Cancer Res 2010, 8:1002-1016.
160. Walczak H., Krammer P.H. The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Exp Cell Res 2000, 256:58-66.
161. Wan K.F., Wang S., Brown C.J., Yu V.C., Entzeroth M., Lane D.P., et al. Differential scanning fluorimetry as secondary screening platform for small molecule inhibitors of Bcl-XL. Cell Cycle 2009, 8:3943-3952.
162. Wang G., Wang J.J., Yang G.Y., Du S.M., Zeng N., Li D.S., et al. Effects of quercetin nanoliposomes on C6 glioma cells through induction of type III programmed cell death. Int J Nanomedicine 2012, 7:271-280.
163. Wang H.C., Pao J., Lin S.Y., Sheen L.Y. Molecular mechanisms of garlic-derived allyl sulfides in the inhibition of skin cancer progression. Ann N Y Acad Sci 2012, 1271:44-52.
164. Wei L., Liu J.J., Cao J., Du N.C., Ji L.N., Yang X.L. Role of autophagy in quercetin-induced apoptosis in human bladder carcinoma BIU-87 cells. Zhonghua Zhong Liu Za Zhi 2012, 34:414-418. [Chinese journal of oncology].
165. Wirawan E., Vande Walle L., Kersse K., Cornelis S., Claerhout S., Vanoverberghe I., et al. Caspase-mediated cleavage of Beclin-1 inactivates Beclin-1-induced autophagy and enhances apoptosis by promoting the release of proapoptotic factors from mitochondria. Cell Death Dis 2010, 1:e18.
166. Yang J.S., Chen G.W., Hsia T.C., Ho H.C., Ho C.C., Lin M.W., et al. Diallyl disulfide induces apoptosis in human colon cancer cell line (COLO 205) through the induction of reactive oxygen species, endoplasmic reticulum stress, caspases cascade and mitochondrial-dependent pathways. Food Chem Toxicol 2009, 47:171-179.
167. Yousefi S., Perozzo R., Schmid I., Ziemiecki A., Schaffner T., Scapozza L., et al. Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat Cell Biol 2006, 8:1124-1132.
168. Yu L., Alva A., Su H., Dutt P., Freundt E., Welsh S., et al. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 2004, 304:1500-1502.
169. Yu L., Strandberg L., Lenardo M.J. The selectivity of autophagy and its role in cell death and survival. Autophagy 2008, 4:567-573.
170. Zhang Y.H., Bhunia A., Wan K.F., Lee M.C., Chan S.L., Yu V.C., et al. Chelerythrine and sanguinarine dock at distinct sites on BclXL that are not the classic BH3 binding cleft. J Mol Biol 2006, 364:536-549.
171. Zhang D., Qiu L., Jin X., Guo Z., Guo C. Nuclear factor-kappaB inhibition by parthenolide potentiates the efficacy of Taxol in non-small cell lung cancer in vitro and in vivo. Mol Cancer Res 2009, 7:1139-1149.
172. Zhang H., Zhou X., McQuade T., Li J., Chan F.K., Zhang J. Functional complementation between FADD and RIP1 in embryos and lymphocytes. Nature 2011, 471:373-376.
173. Zheng L.F., Wei Q.Y., Cai Y.J., Fang J.G., Zhou B., Yang L., et al. DNA damage induced by resveratrol and its synthetic analogues in the presence of Cu (II) ions: mechanism and structure-activity relationship. Free Radic Biol Med 2006, 41:1807-1816.
174. Zheng L.F., Dai F., Zhou B., Yang L., Liu Z.L. Prooxidant activity of hydroxycinnamic acids on DNA damage in the presence of Cu(II) ions: mechanism and structure-activity relationship. Food Chem Toxicol 2008, 46:149-156.
175. Zou H., Henzel W.J., Liu X., Lutschg A., Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 1997, 90:405-413.
176. Zubair H., Khan H.Y., Sohail A., Azim S., Ullah M.F., Ahmad A., et al. Redox cycling of endogenous copper by thymoquinone leads to ROS-mediated DNA breakage and consequent cell death: putative anticancer mechanism of antioxidants. Cell Death Dis 2013, 4:e660.